Molecular basis of protein S deficiency

Thrombosis and Haemostasis

Volumn 98, Issue 3, 2007, Pages 543-556

  de Frutos, Pablo García ^a   Fuentes Prior, Pablo ^b   Hurtado, Begoña ^c   Sala, Núria ^c  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b Institut Català de Ciències Cardiovasculars   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Mutations; Natural anticoagulants; PROSI; Protein S; Thrombophilia; Vitamin K

Indexed keywords

EPIDERMAL GROWTH FACTOR; GENE PRODUCT; PEPTIDE; PROTEIN PROS1; PROTEIN S; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANTICOAGULATION; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; ENZYME ACTIVITY; GENE DELETION; GENE MUTATION; HEMOSTASIS; HETEROZYGOSITY; HUMAN; IN VITRO STUDY; INFLAMMATION; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN S DEFICIENCY; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 34548692763     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-03-0199     Document Type: Article

References (160)

1. DiScipio RG, Davie EW. Characterization of protein S, a gamma-carboxyglutamic acid containing protein from bovine and human plasma. Biochemistry 1979; 18: 899-904.
2. Walker FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem 1980; 255: 5521-5524.
3. Comp PC, Nixon RR, Cooper MR, et al. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984; 74: 2082-2088.
4. Schwarz HP, Fischer M, Hopmeier P, et al. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64: 1297-1300.
5. Esmon CT. The protein C pathway. Chest 2003; 124: 26S-32S.
6. Dahlbäck B, Villoutreix BO. The anticoagulant protein C pathway. FEBS Lett 2005; 579: 3310-3316.
7. Franchini M, Veneri D. Inherited thrombophilia: an update. Clin Lab 2005; 51: 357-365.
8. Gandrille S, Borgel D, Sala N, et al. Protein S deficiency: a database of mutations - summary of the first update. Thromb Haemost 2000; 84: 918.
9. Furie B, Bouchard BA, Furie BC. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 1999; 93: 1798-1808.
10. Stenflo J. Contributions of Gla and EGF-like domains to the fanction of vitamin K-dependent coagulation factors. Crit Rev Eukaryot Gene Expr 1999; 9: 59-88.
11. Walker FJ. Regulation of vitamin K-dependent protein S. Inactivation by thrombin. J Biol Chem 1984; 259: 10335-10339.
12. Dahlbäck B, Lundwall A, Stenflo J. Localization of thrombin cleavage sites in the amino-terminal region of bovine protein S. J Biol Chem 1986; 261: 5111-5115.
13. Lu D, Xie RL, Rydzewski A, et al. The effect of N-linked glycosylation on molecular weight, thrombin cleavage, and functional activity of human protein S. Thromb Haemost 1997; 77: 1156-1163.
14. Long GL, Lu D, Xie RL, et al. Human protein S cleavage and inactivation by coagulation factor Xa. J Biol Chem 1998; 273: 11521-11526.
15. Giri TK, Villoutreix BO, Wallqvist A, et al. Topological studies of the amino terminal modules of vitamin K-dependent protein S using monoclonal anti-body epitope mapping and molecular modeling. Thromb Haemost 1998; 80: 798-804.
16. Dahlbäck B, Hildebrand B, Malm J. Characterization of functionally important domains in human vitamin K-dependent protein S using monoclonal anti-bodies. J Biol Chem 1990; 265: 8127-8135.
17. Stenberg Y, Linse S, Drakenberg T, et al. The high affinity calcium-binding sites in the epidermal growth factor module region of vitamin K-dependent protein S. J Biol Chem 1997; 272: 23255-23260.
18. Nelson RM, VanDusen WJ, Friedman PA, et al. beta-Hydroxyaspartic acid and beta-hydroxyasparagine residues in recombinant human protein S are not required for anticoagulant cofactor activity or for binding to C4b-binding protein. J Biol Chem 1991; 266: 20586-20589.
19. Villoutreix BO, García de Frutos, Lovenklev M, et al. SHBG region of the anticoagulant cofactor protein S: secondary structure prediction, circular dichroism spectroscopy, and analysis of naturally occurring mutations. Proteins 1997; 29: 478-491.
20. Evenas P, García de Frutos, Linse S, et al. Both G-type domains of protein S are required for the high-affinity interaction with C4b-binding protein. Eur J Biochem 1999; 266: 935-942.
21. Giri TK, Linse S, García de Frutos, et al. Structural requirements of anticoagulant protein S for its binding to the complement regulator C4b-binding protein. J Biol Chem 2002; 277: 15099-15106.
22. Villoutreix BO, Dahlbáck B, Borgel D, et al. Three-dimensional model of the SHBG-like region of anticoagulant protein S: new structure-function insights. Proteins 2001; 43: 203-216.
23. Giri TK, Yamazaki T, Sala N, et al. Deficient APC-cofactor activity of protein S Heerlen in degradation of factor Va Leiden: a possible mechanism of synergism between thrombophilic risk factors. Blood 2000; 96: 523-531.
24. Drakenberg T, Ghasriani H, Thulin E, et al. Solution structure of the Ca2+-Binding EGF3-4 pair from vitamin K-dependent protein S: identification of an unusual fold in EGF3. Biochemistry 2005; 44: 8782-8789.
25. Fuentes-Prior P, Iwanaga Y, Huber R, et al. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature 2000; 404: 518-525.
26. Hambleton S, Valeyev NV, Muranyi A, et al. Structural and functional properties of the human Notch-1 ligand binding region. Structure 2004; 12: 2173-2183.
27. Sasaki T, Knyazev PG, Cheburkin Y, et al. Crystal structure of a C-terminal fragment of growth arrest-specific protein Gas6 - Receptor tyrosine kinase activation by laminin G-like domains. J Biol Chem 2002; 277: 44164-44170.
28. Sasaki T, Knyazev PG, Clout NJ, et al. Structural basis for Gas6-Axl signalling. Embo J 2006; 25: 80-87.
29. Villoutreix BO, Teleman O, Dablbäck B. A theoretical model for the Gla-TSR-EGF-1 region of the anticoagulant cofactor protein S: from biostructural pathology to species-specific cofactor activity. J Comput Aided Mol Des 1997; 11: 293-304.
30. Giri TV, de Frutos PG, Yamazaki T, et al. In vitro characterisation of two naturally occurring mutations in the thrombin-sensitive region of anticoagulant protein S. Thromb Haemost 1999; 82: 1627-1633.
31. He X, Shen L, Villoutreix BO, et al. Amino acid residues in thrombin-sensitive region and first epidermal growth factor domain of vitamin K-dependent protein S determining specificity of the activated protein C cofactor function. J Biol Chem 1998; 273: 27449-27458.
32. Stenberg Y, Drakenberg T, Dahlbäck B, et al. Characterization of recombinant epidermal growth factor (EGF)-like modules from vitamin-K-dependent protein S expressed in Spodoptera cells - the cofactor activity depends on the N-terminal EGF module in human protein S. Eur J Biochem 1998; 251: 558-564.
33. van Wijnen M, Stam JG, Chang GT, et al. Characterization of mini-protein S, a recombinant variant of protein S that lacks the sex hormone binding globulin-like domain. Biochem J 1998; 330: 389-396.
34. Nicolaes GA, Dahlbäck B. Factor V and thrombotic disease: description of a janus-faced protein. Arterioscler Thromb Vasc Biol 2002; 22: 530-538.
35. Nyberg P, Dahlbäck B, García de Frutos. The SHBG-like region of protein S is crucial for factor V-dependent APC-cofactor function. FEBS Lett 1998; 433: 28-32.
36. Yegneswaran S, Smirnov MD, Safa O, et al. Relocating the active site of activated protein C eliminates the need for its protein S cofactor. A fluorescence resonance energy transfer study. J Biol Chem 1999; 274: 5462-5468.
37. Rosing J, Tans G. Coagulation factor V: an old star shines again. Thromb Haemost 1997; 78: 427-433.
38. Griffin JH, Kojima K, Banka CL, et al. High-density lipoprotem enhancement of anticoagulant activities of plasma protein S and activated protein C. J Clin Invest 1999; 103: 219-227.
39. Xu N, Dahlbäck B, Ohlin AK, et al. Association of vitamin K-dependent coagulation proteins and C4b binding protein with triglyceride-rich lipoproteins of human plasma. Arterioscler Thromb Vasc Biol 1998; 18: 33-39.
40. Denis CV, Roberts SJ, Hackeng TM, et al. In vivo clearance of human protein S in a mouse model: influence of C4b-binding protein and the Heerlen polymorphism. Arterioscler Thromb Vasc Biol 2005; 25: 2209-2215.
41. Dahlbäck B. Protein S and C4-binding protein: components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 1991; 66: 49-61.
42. Rezende SM, Simmonds RE, Lane DA. Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex. Blood 2004; 103: 1192-1201.
43. Hillarp A, Wiklund H, Thern A, et al. Molecular cloning of rat C4b binding protein alpha- and beta-chains: structural and functional relationships among human, bovine, rabbit, mouse, and rat proteins. J Immunol 1997; 158: 1315-1323.
44. Hillarp A, Them A, Dahlbäck B. Bovine C4b binding protein. Molecular cloning of the alpha- and beta-chains provides structural background for lack of complex formation with protein S. J Immunol 1994; 153: 4190-4199.
45. García de Frutos, Dahlbäck B. cDNA structure of rabbit C4b-binding protein alpha-chain. Preserved sequence motive in complement regulatory protein modules which bind C4b. Biochim Biophys Acta 1995; 1261: 285-289.
46. Hillarp A, Dahlbäck B. Novel subunit in C4b-binding protein required for protein S binding. J Biol Chem 1988; 263: 12759-12764.
47. Rodriguez de Córdoba S, Perez-Blas M, Ramos-Ruiz R, et al. The gene coding for the beta-chain of C4b-binding protein (C4BPB) has become a pseudo-gene in the mouse. Genomics 1994; 21: 501-509.
48. Dahlbäck B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem 1986; 261: 12022-12027.
49. Griffin JH, Gruber A, Fernández JA. Reevaluation of total, free, and bound protein S and C4b-binding protein levels in plasma anticoagulated with citrate or hirudin. Blood 1992; 79: 3203-3211.
50. García de Frutos, Alim RI, Hardig Y, et al. Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S. Blood 1994; 84: 815-822.
51. Heeb MJ, Mesters RM, Tans G, et al. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 1993; 268: 2872-2877.
52. Heeb MJ, Radtke KP, Fernandez JA, et al. Plasma contains protein S monomers and multimers with similar direct anticoagulant activity. J Thromb Haemost 2006; 4: 2215-2222.
53. Heeb MJ, Schuck P, Xu X. Protein S multimers and monomers each have direct anticoagulant activity. J Thromb Haemost 2006; 4: 385-391.
54. Heeb MJ, Griffin JH. Activated protein C-dependent and -independent anticoagulant activities of protein S have different structural requirements. Blood Cells Mol Dis 2002; 29: 190-199.
55. van Wijnen M, Stam JG, van't Veer C, et al. The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein S. Thromb Haemost 1996; 76: 397-403.
56. van Wijnen M, van't Veer C, Meijers JC, et al. A plasma coagulation assay for an activated protein C-independent anticoagulant activity of protein S. Thromb Haemost 1998; 80: 930-935.
57. Koppelman SJ, van't Veer C, Sixma JJ, et al. Synergistic inhibition of the intrinsic factor X activation by protein S and C4b-binding protein. Blood 1995; 86: 2653-2660.
58. Hackeng TM, Sere KM, Tans G, et al. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci USA 2006; 103: 3106-3111.
59. Martinelli I, Mannucci PM, De S, V, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 1998; 92: 2353-2358.
60. Manucci PM. The molecular basis of inherited thrombophilia. Vox Sang 2000; 78 (Suppl 2): 39-45.
61. Simioni P, Tormene D, Spiezia L, et al. Inherited thrombophilia and venous thromboembolism. Sem Thromb Hemost 2006; 32: 700-708.
62. Miyata T, Kimura R, Kokubo Y, et al. Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation. Int J Hematol 2006; 83: 217-223.
63. Suehisa E, Nomura T, Kawasaki T, et al. Frequency of natural coagulation inhibitor (antithrombin III, protein C and protein S) deficiencies in Japanese patients with spontaneous deep vein thrombosis. Blood Coagul Fibrinolysis 2001; 12: 95-99.
64. Biguzzi E, Razzari C, Lane DA, et al. Molecular diversity and thrombotic risk in protein S deficiency: the PROSIT study. Hum Mutat 2005; 25: 259-269.
65. Gomez E, Ledford MR, Pegelow CH, et al. Homozygous protein S deficiency due to a one base pair deletion that leads to a stop codon in exon III of the protein S gene. Thromb Haemost 1994; 71: 723-726.
66. Mahasandana C, Veerakul G, Tanphaichitr VS, et al. Homozygous protein S deficiency: 7-year follow-up. Thromb Haemost 1996; 76: 1122.
67. Pabinger I, Schneider B. Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose- und Hamostaseforschung (GTH) Study Group on Natural Inhibitors. Arterioscler Thromb Vasc Biol 1996; 16: 742-748.
68. Simmonds RE, Ireland H, Lane DA, et al. Clarification of the risk for venous thrombosis associated with hereditary protein S deficiency by investigation of a large kindred with a characterized gene defect. Ann Intern Med 1998; 128: 8-14.
69. Faioni EM, Valsecchi C, Palla A, et al. Free protein S deficiency is a risk factor for venous thrombosis. Thromb Haemost 1997; 78: 1343-1346.
70. Persson KE, Dahlbäck B, Hillarp A. Diagnosing protein S deficiency: analytical considerations. Clin Lab 2003; 49: 103-110.
71. Meijer P, Haverkate F, Kluft C. Performance goals for the laboratory testing of antithrombin, protein C and protein S. Thromb Haemost 2006; 96: 584-589.
72. Makris M, Leach M, Beauchamp NJ, et al. Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S. Blood 2000; 95: 1935-1941.
73. Brouwer JL, Veeger NJ, van der SW, et al. Difference in absolute risk of venous and arterial thrombosis between familial protein S deficiency type I and type III. Results from a family cohort study to assess the clinical impact of a laboratory test-based classification. Br J Haematol 2005; 128: 703-710.
74. Aiach M, Borgel D, Gaussem P, et al. Protein C and protein S deficiencies. Semin Hematol 1997; 34: 205-216.
75. Woodward M, Lowe GD, Rumley A, et al, Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol 1997; 97: 785-797.
76. Henkens CM, Bom VJ, van der SW et al. Plasma levels of protein S, protein C, and factor X: effects of sex, hormonal state and age. Thromb Haemost 1995; 74: 1271-1275.
77. Dykes AC, Walker ID, McMahon AD, et al. A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol 2001; 113: 636-641.
78. Sakata T, Okamoto A, Mannami T, et al. Prevalence of protein S deficiency in the Japanese general population: The Suita Study. J Thromb Haemost 2004; 2: 1012-1013.
79. Brunet D, Barthet MC, Morange PE, et al. Protein S deficiency: Different biological phenotypes according to the assays used. Thromb Haemost 1998; 79: 446-447.
80. Giri TK, Hillarp A, Hardig Y, et al. A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen. Thromb Haemost 1998; 79: 767-772.
81. Libourel EJ, Bank I, Veeger NJ, et al. Protein S type III deficiency is no risk factor for venous and arterial thromboembolism in 168 thrombophilic families: a retrospective study. Blood Coagul Fibrinolysis 2005; 16: 135-140.
82. Rezende SM, Lane DA, Zöller B, et al. Genetic and phenotypic variability between families with hereditary protein S deficiency. Thromb Haemost 2002; 87: 258-265.
83. Simmonds RE, Zöller B, Ireland H, et al. Genetic and phenotypic analysis of a large (122-member) protein S-deficient kindred provides an explanation for the familial coexistence of type I and type III plasma phenotypes. Blood 1997; 89: 4364-4370.
84. Espinosa-Parrilla Y, Yamazaki T, Sala N, et al. Protein S secretion differences of missense mutants account for phenotypic heterogeneity. Blood 2000; 95: 173-179.
85. Zöller B, García de Frutos P, Dahlbäck B. Evaluation of the relationship between protein-S and C4B-binding protein isoforms in hereditary protein-S deficiency demonstrating type-I and type-III deficiencies to be phenotypic variants of the same genetic disease. Blood 1995; 85: 3524-3531.
86. Espinosa-Parrilla Y, Morell M, Souto JC, et al. Protein S gene analysis reveals the presence of a cosegregating mutation in most pedigrees with type I but not type III PS deficiency. Hum Mutat 1999; 14: 30-39.
87. Espinosa-Parrilla Y, Morell M, Souto JC, et al. Absence of linkage between type III protein S deficiency and the PROS1 and C4BP genes in families carrying the protein S Heerlen allele. Blood 1997; 89: 2799-2806.
88. Bertina RM, Ploos van Amstel HK, van Wijngaarden A, et al. Heerlen polymorphism of protein S, an immunologic polymorphism due to dimorphism of residue 460. Blood 1990; 76: 538-548.
89. Beauchamp NJ, Dykes AC, Parikh N, et al. The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population. Br J Haematol 2004; 125: 647-654.
90. Gandrille S, Aiach M. Identification of mutations in 90 of 121 consecutive symptomatic French patients with a type I protein C deficiency. The French INSERM Network on Molecular Abnormalities Responsible for Protein C and Protein S deficiencies. Blood 1995; 86: 2598-2605.
91. Espinosa-Parrilla Y, Morell M, Borrell M, et al. Optimization of a simple and rapid single-strand conformation analysis for detection of mutations in the PROS1 gene: identification of seven novel mutations and three novel, apparently neutral, variants. Hum Mutat 2000; 15: 463-473.
92. Tatewaki H, Tsuda H, Kanaji T, et al. Characterization of the human protein S gene promoter: a possible role of transcription factors Sp1 and HNF3 in liver. Thromb Haemost 2003; 90: 1029-1039.
93. Hall AJ, Peake IR, Winship PR. Regulation of the human protein S gene promoter by liver enriched transcription factors. Br J Haematol 2006; 135: 538-546.
94. de Wolf CJ, Cupers RM, Bertina RM, et al. Interleukin-6 induction of protein s is regulated through signal transducer and activator of transcription 3. Arterioscler Thromb Vasc Biol 2006; 26: 2168-2174.
95. de Wolf CJ, Cupers RM, Bertina RM, et al. The constitutive expression of anticoagulant protein S is regulated through multiple binding sites for Sp1 and Sp3 transcription factors in the protein S gene promoter. J Biol Chem 2006; 281: 17635-17643.
96. Lanke E, Johansson AM, Hillarp A, et al. Co-segregation of the PROS1 locus and protein S deficiency in families having no detectable mutations in PROS1. J Thromb Haemost 2004; 2: 1918-1923.
97. Johansson AM, Hillarp A, Sall T, et al. Large deletions of the PROSI gene in a large fraction of mutation-negative patients with protein S deficiency. Thromb Haemost 2005; 94: 951-957.
98. Heinikari T, Huoponen O, Partanen J, et al. Protein S gene polymorphisms Pro626 and nt2698 - no correlation to free protein S levels or protein S activities. Thromb Haemost 2005; 94: 1340-1341.
99. Mustafa S, Pabinger I, Mannhalter C. Protein S deficiency type I: identification of point mutations in 9 of 10 families. Blood 1995; 86: 3444-3451.
100. Reitsma PH, Vanamstel HKP, Bertina RM. 3 Novel Mutations in 5 Unrelated Subjects with Hereditary Protein-S Deficiency Type-1. J Clin Invest 1994; 93: 486-492.
101. Yamazaki T, Hamaguchi M, Katsumi A, et al. A quantitative protein-S deficiency associated with a novel nonsense mutation and markedly reduced levels of mutated messenger-Rna. Thromb Haemost 1995; 74: 590-595.
102. Maquat LE. Nonsense-mediated mRNA decay: Splicing, translation and mRNP dynamics. Nature Rev Mol Cell Biol 2004; 5: 89-99.
103. Yamazaki T, Katsumi A, Kagami K, et al. Molecular basis of a hereditary type I protein S deficiency caused by a substitution of Cys for Arg474. Blood 1996; 87: 4643-4650.
104. ten Kate MK, Mulder R, Platteel M, et al. Identification of a novel PROS1 c. 1113T ->GG frameshift mutation in a family with mixed type I/ type III protein S deficiency. Haematologica 2006; 91: 1151-1152.
105. Giri TK, García de Frutos, Dahlbäck B. Protein S Thr103Asn mutation associated with type II deficiency reproduced in vitro and functionally characterised. Thromb Haemost 2000; 84: 413-419.
106. Okada H, Yamazaki T, Takagi A, et al. In vitro characterization of missense mutations associated with quantitative protein S deficiency J Thromb, Haemost 2006; 4: 2003-2009.
107. Tsuda H, Urata M, Tsuda T, et al. Four missense mutations identified in the protein S gene of thrombosis patients with protein S deficiency: effects on secretion and anticoagulant activity of protein S. Thromb Res 2002; 105: 233-239.
108. Espinosa-Parrilla Y, Navarro G, Morell M, et al. Homozygosity for the protein S Heerlen allele is associated with type I PS deficiency in a thrombophilic pedigree with multiple risk factors. Thromb Haemost 2000; 83: 102-106.
109. Duchemin J, Gandrille S, Borgel D, et al. The Ser 460 to Pro substitution of the protein-S-alpha (Pros1) gene is a frequent mutation associated with free protein-S (type-Iia) deficiency. Blood 1995; 86: 3436-3443.
110. Esparza-Gordillo J, Soria JM, Buil A, et al. Genetic determinants of variation in the plasma levels of the C4b-binding protein (C4BP) in Spanish families. Immunogenetics 2003; 54: 862-866.
111. Criado-García O, González-Rubio C, López-Trascasa M, et al. Modulation of C4b-binding protein isoforms during the acute phase response caused by orthopedic surgery. Haemostasis 1997; 27: 25-34.
112. Morboeuf O, Aiach M, Gandrille S. Lack of sequence variations in the C4b-BP beta-chain in patients with type III protein S deficiency bearing the Ser 460 to Pro mutation: description of two new intragenic isomorphisms in the C4b-BP beta-chain gene (C4BPB). Br J Haematol 1998; 101: 10-15.
113. Leroy-Matheron C, Gouault-Heilmann M, Aiach M, et al. A mutation of the active protein S gene leading to an EGF1-lacking protein in a family with qualitative (type II) deficiency. Blood 1998; 91: 4608-4615.
114. Baroni M, Mazzola G, Kaabache T, et al. Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function. J Thromb Haemost 2006; 4: 186-191.
115. Rockwell NC, Thorner JW. The kindest cuts of all: crystal structures of Kex2 and furin reveal secrets of precursor processing. Trends Biochem Sci 2004; 29: 80-87.
116. Simmonds RE, Ireland H, Kunz G, et al. Identification of 19 protein S gene mutations in patients with phenotypic protein S deficiency and thrombosis. Protein S Study Group. Blood 1996; 88: 4195-4204.
117. Razzari C, Franchi F, Biguzzi E. Protein S binding to phospholipids: evaluation of eight variants of recombinant human protein S from the PROSIT study. J Thromb Haemost 2006; 4: 273-274.
118. Rezende SM, Lane DA, Mille-Baker B, et al. Protein S Gla-domain mutations causing impaired Ca2+-induced phospholipid binding and severe functional protein S deficiency. Blood 2002; 100: 2812-2819.
119. Boinot C, Borgel D, Kitzis A, et al. Familial thrombophilia is an oligogenetic disease: involvement of the prothrombin G20210A, PROC and PROS gene mutations. Blood Coagul Fibrinolysis 2003; 14: 191-196.
120. Franchi F, Viscardi Y, Razzari C, et al. c.301C>T (p.Arg101Cys): a novel mutation in the thrombin-sensitive region of protein S associated with a dysfunctional protein. Thromb Haemost 2006; 96: 381-383.
121. Borgel D, Duchemin J, Alhene-Gelas M, et al. Molecular basis for protein S hereditary deficiency: genetic defects observed in 118 patients with type I and type IIa deficiencies. The French Network on Molecular Abnormalities Responsible for Protein C and Protein S Deficiencies. J Lab Clin Med 1996; 128: 218-227.
122. Okada H, Takagi A, Murate T, et al. Identification of protein Salpha gene mutations including four novel mutations in eight unrelated patients with protein S deficiency. Br J Haematol 2004; 126: 219-225.
123. Hermida J, Faioni EM, Mannucci PM. Poor relationship between phenotypes of protein S deficiency and mutations in the protein S alpha gene. Thromb Haemost 1999; 82: 1634-1638.
124. Beauchamp NJ, Daly ME, Cooper PC, et al. Molecular basis of protein S deficiency in three families also showing independent inheritance of factor V leiden. Blood 1996; 88: 1700-1707.
125. Andersen BD, Bisgaard ML, Lind B, et al. Characterization and structural impact of five novel PROS1 mutations in eleven protein S-deficient families. Thromb Haemost 2001; 86: 1392-1399.
126. Formstone CJ, Wacey AI, Berg LP, et al. Detection and characterization of seven novel protein S (PROS) gene lesions: evaluation of reverse transcript-polymerase chain reaction as a mutation screening strategy. Blood 1995; 86: 2632-2641.
127. Persson KE, Stenflo J, Linse S, et al. Binding of calcium to anticoagulant protein S: role of the fourth EGF module. Biochemistry 2006; 45: 10682-10689.
128. Iwaki T, Mastushita T, Kobayashi T, et al. DNA sequence analysis of protein S deficiency - identification of four point mutations in twelve Japanese subjects. Semin Thromb Hemost 2001; 27: 155-160.
129. Hayashi T, Nishioka J, Shigekiyo T, et al. Protein S Tokushima: abnormal molecule with a substitution of Glu for Lys- 155 in the second epidermal growth factor-like domain of protein S. Blood 1994; 83: 683-690.
130. Yamazaki T, Sugiura I, Matsushita T, et al. A phenotypically neutral dimorphism of protein S: the substitution of Lys 155 by Glu in the second EGF domain predicted by an A to G base exchange in the gene. Thromb Res 1993; 70: 395-403.
131. Kimura R, Kokubo Y, Miyashita K, et al. Polymorphisms in vitamin K-dependent gamma-carboxylation-related genes influence interindividual variability in plasma protein C and protein S activities in the general population. Int J Hematol 2006; 84: 387-397.
132. Hayashi T, Nishioka J, Suzuki K. Molecular mechanism of the dysfunction of protein S(Tokushima) (Lys155 ->Glu) for the regulation of the blood coagulation system. Biochim Biophys Acta 1995; 1272: 159-167.
133. Bustorff TC, Freire I, Gago T, et al. Identification of three novel mutations in hereditary protein S deficiency. Thromb Haemost 1997; 77: 21-25.
134. Duchemin J, Borg JY, Borgel D, et al. Five novel mutations of the protein S active gene (PROS1) in 8 Norman families. Thromb Haemost 1996; 75: 437-444.
135. Evenas P, García de Frutos, Nicolaes GA, et al. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa. Thromb Haemost 2000; 84: 271-277.
136. Heeb MJ, Kojima Y, Rosing J, et al. C-terminal residues 621-635 of protein S are essential for binding to factor Va. J Biol Chem 1999; 274: 36187-36192.
137. Borgel D, Jude B, Aiach M, et al. First case of sporadic protein S deficiency due to a novel candidate mutation, Ala 484-->Pro, in the protein S active gene (PROS1). Thromb Haemost 1996; 75: 883-886.
138. Nicolaes GA, Hackeng TM, Segers K, et al. A structural model of the SHBG domain of human variant protein S Heerlen. Thromb Haemost 2006; 96: 538-540.
139. Koenen RR, Gomes L, Tans G, et al. The Ser460Pro mutation in recombinant protein S Heerlen does not affect its APC-cofactor and APC-independent anticoagulant activities. Thromb Haemost 2004; 91: 1105-1114.
140. Heeb MJ, Koenen RR, Fernández JA, et al. Direct anticoagulant activity of protein S-C4b binding protein complex in Heerlen heterozygotes and normals. J Thromb Haemost 2004; 2: 1766-1773.
141. Greengard JS, Fernandez JA, Radtke KP, et al. Identification of candidate residues for interaction of protein S with C4b binding protein and activated protein C. Biochem J 1995; 305: 397-403.
142. Fuentes-Prior P, Fujikawa K, Pratt KP. New insights into binding interfaces of coagulation factors V and VIII and their homologues lessons from high resolution crystal structures. Curr Protein Pept Sci 2002; 3: 313-339.
143. Li M, Long GL. Identification of two novel point mutations in the human protein S gene associated with familial protein S deficiency and thrombosis. Arterioscler Thromb Vasc Biol 1996; 16: 1407-1415.
144. Mustafa S, Mannhalter C, Rintelen C, et al. Clinical features of thrombophilia in families with gene defects in protein C or protein S combined with factor V Leiden. Blood Coagul Fibrinolysis 1998; 9: 85-89.
145. Salomon O, Steinberg DM, Zivelin A, et al. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol 1999; 19: 511-518.
146. Brugge JM, Tans G, Rosing J, et al. Protein S levels modulate the activated protein C resistance phenotype induced by elevated prothrombin levels. Thromb Haemost 2006; 95: 236-242.
147. Kanaji T, Watanabe K, Hattori S, et al. Factor XII gene (F12)-4C/C polymorphism in combination with low protein S activity is associated with deep vein thrombosis. Thromb Haemost 2006; 96: 854-855.
148. Zöller B, García de Frutos, Dahlbäck B. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency. Thromb Haemost 1998; 79: 802-807.
149. Esmon NL, Safa O, Smirnov MD, et al. Antiphospholipid antibodies and the protein C pathway. J Autoimmun 2000; 15: 221-225.
150. Rand JH. The antiphospholipid syndrome. Annu Rev Med 2003; 54: 409-424.
151. Wu O, Robertson L, Langhorne P et al. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study Thromb Haemost 2005; 94: 17-25.
152. Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood 2007; 109: 3161-3172.
153. Liu D, Guo H, Griffin JH, et al. Protein S confers neuronal protection during ischemic/hypoxic injury in mice. Circulation 2003; 107: 1791-1796.
154. Esmon CT. Crosstalk between inflammation and thrombosis. Maturitas 2004; 47: 305-314.
155. Smiley ST, Boyer SN, Heeb MJ, et al. Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity. Proc Natl Acad Sci USA 1997; 94: 11484-11489.
156. Rigby AC, Grant MA. Protein S: a conduit between anticoagulation and inflammation. Crit Care Med 2004; 32: S336-S341.
157. Hafizi S, Dahlbäck B. Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. FEBS J 2006; 273: 5231-5244.
158. Prasad D, Rothlin CV, Burrola P, et al. TAM receptor function in the retinal pigment epithelium. Mol Cell Neurosci 2006; 33: 96-108.
159. Anderson HA, Shacter E. Natural anticoagulant proteins in the regulation of autoimmunity: potential role of protein S. Curr Pharm Des 2004; 10: 929-937.
160. Benzakour O, Kanthou C. The anticoagulant factor, protein S, is produced by cultured human vascular smooth muscle cells and its expression is up-regulated by thrombin. Blood 2000; 95: 2008-2014.